Livongo Raises $105M As Mobile Diabetes Monitoring Takes Off
Livongo Health has raised $105 million more as the business of mobile monitoring technology to manage chronic conditions attracts big names in technology, health insurance and the investor community.
In the case of Livongo, the fast-growing startup said the new funding round is led by General Catalyst and Kinnevik. Also participating in the funding are Echo Health Ventures and existing investors DFJ, Kleiner Perkins Caufield & Byers, Merck Global Health Innovation Fund, Microsoft Ventures, Sapphire Ventures, Zaffre Investments, and 7wire Ventures…
Read the rest of the article on Forbes